|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
DE4013632A1
(de)
|
1990-04-27 |
1991-10-31 |
Max Planck Gesellschaft |
Liposomen mit positiver ueberschussladung
|
|
PT951551E
(pt)
|
1996-12-23 |
2008-10-28 |
Immunex Corp |
Ligando para receptor activador de nf-kb, ligando membro da superfamília de tnf
|
|
US6316408B1
(en)
|
1997-04-16 |
2001-11-13 |
Amgen Inc. |
Methods of use for osetoprotegerin binding protein receptors
|
|
US6274338B1
(en)
|
1998-02-24 |
2001-08-14 |
President And Fellows Of Harvard College |
Human c-Maf compositions and methods of use thereof
|
|
EA200100972A1
(ru)
|
1999-03-15 |
2002-02-28 |
Аксис Фармасьютикалз, Инк. |
Новые соединения и композиции как ингибиторы протеаз
|
|
JP2003525874A
(ja)
|
2000-01-06 |
2003-09-02 |
メルク フロスト カナダ アンド カンパニー |
プロテアーゼ阻害剤としての新規化合物および組成物
|
|
CA2451955C
(en)
|
2001-06-26 |
2015-09-29 |
Abgenix, Inc. |
Antibodies to opgl
|
|
GB0121033D0
(en)
|
2001-08-30 |
2001-10-24 |
Novartis Ag |
Organic compounds
|
|
AR036375A1
(es)
|
2001-08-30 |
2004-09-01 |
Novartis Ag |
Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
|
|
KR100485271B1
(ko)
|
2002-01-16 |
2005-04-27 |
메타볼랩(주) |
전사인자 ｃ－ｍａｆ의 전사 활성 억제제로서의 니발레놀및 그를 포함하는 약제학적 조성물
|
|
SE0201980D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
|
DE10235624A1
(de)
|
2002-08-02 |
2004-02-19 |
Aventis Pharma Deutschland Gmbh |
Endiandric acid H und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben
|
|
US20050181375A1
(en)
|
2003-01-10 |
2005-08-18 |
Natasha Aziz |
Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer
|
|
JP4579246B2
(ja)
|
2003-09-24 |
2010-11-10 |
オンコセラピー・サイエンス株式会社 |
乳癌を診断する方法
|
|
WO2005046731A1
(en)
|
2003-10-17 |
2005-05-26 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Interference with c-maf function in multiple myeloma
|
|
US20090048117A1
(en)
|
2003-12-18 |
2009-02-19 |
President And Fellows Of Harvard College |
Modulation of immune system function by modulation of polypeptide arginine methyltransferases
|
|
TW200526224A
(en)
|
2003-12-22 |
2005-08-16 |
Alcon Inc |
Short form c-Maf transcription factor antagonists for treatment of glaucoma
|
|
US8019552B2
(en)
|
2004-03-05 |
2011-09-13 |
The Netherlands Cancer Institute |
Classification of breast cancer patients using a combination of clinical criteria and informative genesets
|
|
WO2006012221A2
(en)
|
2004-06-25 |
2006-02-02 |
The Regents Of The University Of California |
Target cell-specific short interfering rna and methods of use thereof
|
|
WO2006135436A2
(en)
|
2004-10-22 |
2006-12-21 |
University Of Florida Research Foundation, Inc. |
Inhibition of gene expression and therapeutic uses thereof
|
|
US9134237B2
(en)
|
2005-09-20 |
2015-09-15 |
Janssen Diagnotics, LLC |
High sensitivity multiparameter method for rare event analysis in a biological sample
|
|
JP5457673B2
(ja)
|
2005-09-20 |
2014-04-02 |
ベリデックス・リミテッド・ライアビリティ・カンパニー |
ユニーク配列のｄｎａプローブを作製するための方法および組成物、ｄｎａプローブの標識、ならびにこれらプローブの使用
|
|
US20080219996A1
(en)
|
2005-09-26 |
2008-09-11 |
Thea Kalebic |
Molecular Markers Associated with Bone Metastasis
|
|
WO2008098351A1
(en)
|
2007-02-14 |
2008-08-21 |
University Health Network |
Treatment of d-cyclin mediated proliferative diseases and hemotological malignancies
|
|
EP1961825A1
(en)
|
2007-02-26 |
2008-08-27 |
INSERM (Institut National de la Santé et de la Recherche Medicale) |
Method for predicting the occurrence of metastasis in breast cancer patients
|
|
KR101264473B1
(ko)
|
2007-05-24 |
2013-05-29 |
아블린쓰 엔.브이. |
Ｒａｎｋ-ｌ에 대한 아미노산 서열, 및 이를 포함하는 골 질환 및 장애 치료용 폴리펩티드
|
|
CA2688049A1
(en)
|
2007-05-31 |
2008-12-04 |
Dako Denmark A/S |
Methods for utilizing esr copy number changes in breast cancer treatments and prognoses
|
|
NZ562237A
(en)
|
2007-10-05 |
2011-02-25 |
Pacific Edge Biotechnology Ltd |
Proliferation signature and prognosis for gastrointestinal cancer
|
|
EP2211861A4
(en)
|
2007-10-18 |
2010-08-25 |
Univ Health Network |
CLIOCHINOL FOR THE TREATMENT OF CRUISING BLOOD DISEASES
|
|
US20110130296A1
(en)
|
2008-03-14 |
2011-06-02 |
The Regents Of The University Of California |
Multi-gene classifiers and prognostic indicators for cancers
|
|
CA2726537A1
(en)
|
2008-06-06 |
2009-12-10 |
University Health Network |
8-hydroxyquinoline derivatives for the treatment of hematological malignancies
|
|
ES2338843B1
(es)
|
2008-07-02 |
2011-01-24 |
Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas |
Huella genomica de cancer de mama.
|
|
US8642270B2
(en)
|
2009-02-09 |
2014-02-04 |
Vm Institute Of Research |
Prognostic biomarkers to predict overall survival and metastatic disease in patients with triple negative breast cancer
|
|
JP5705836B2
(ja)
|
2009-05-29 |
2015-04-22 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
Ｈｅｒ２を発現する胃癌患者のｈｅｒ２シグナル伝達のためのモジュレーター
|
|
ES2546410T3
(es)
|
2009-08-06 |
2015-09-23 |
John Wayne Cancer Institute |
Diagnosis de cáncer de mama, y otros tipos de cáncer, de tipo basal primario y metastásico
|
|
DK3091085T3
(da)
|
2010-10-06 |
2019-05-06 |
Inst Catalana Recerca Estudis Avancats |
Fremgangsmåde til at designe en terapi mod brystcancermetastase
|
|
CA2826657A1
(en)
|
2011-02-04 |
2012-08-09 |
Bioarray Therapeutics, Inc. |
Methods of using gene expression signatures to select a method of treatment, predict prognosis, survival, and/or predict response to treatment
|
|
US9066963B2
(en)
|
2011-03-15 |
2015-06-30 |
The University Of North Carolina At Chapel Hill |
Methods of treating breast cancer with anthracycline therapy
|
|
EP2780469A1
(en)
|
2011-11-18 |
2014-09-24 |
Vanderbilt University |
Markers of triple-negative breast cancer and uses thereof
|
|
EP2650682A1
(en)
|
2012-04-09 |
2013-10-16 |
Fundació Privada Institut de Recerca Biomèdica |
Method for the prognosis and treatment of cancer metastasis
|
|
BR112014030750A2
(pt)
|
2012-06-06 |
2017-08-22 |
Inst Catalana Recerca Estudis Avancats |
Método para diagnóstico, prognóstico e tratamento da metástase do câncer pulmonar
|
|
ES2906586T3
(es)
|
2012-10-12 |
2022-04-19 |
Inbiomotion Sl |
Método para el diagnóstico, pronóstico y tratamiento de metástasis de cáncer de próstata
|
|
US10119171B2
(en)
|
2012-10-12 |
2018-11-06 |
Inbiomotion S.L. |
Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
|
|
WO2014140896A2
(es)
|
2013-03-15 |
2014-09-18 |
Fundacio Privada Institut De Recerca Biomedica |
Metodo para el diagnostico, pronostico y tratamiento de la metastasis de un cancer
|
|
WO2014184679A2
(en)
|
2013-03-15 |
2014-11-20 |
Inbiomotion S.L. |
Method for the prognosis and treatment of renal cell carcinoma metastasis
|
|
KR20150122731A
(ko)
*
|
2013-03-15 |
2015-11-02 |
펀다시오 인스티튜트 드 르세르카 바이오메디카 (아이알비 바르셀로나) |
암 전이의 예후 및 치료 방법
|
|
AU2014333513B2
(en)
|
2013-10-09 |
2020-11-26 |
Fundacio Institut De Recerca Biomedica (Irb Barcelona) |
Method for the prognosis and treatment of metastasizing cancer of the bone originating from breast cancer
|
|
EP3229909B1
(en)
|
2014-12-11 |
2020-10-14 |
Inbiomotion S.L. |
Binding members for human c-maf
|
|
MX2018014279A
(es)
|
2016-05-25 |
2019-07-08 |
Inbiomotion Sl |
Tratamiento terapeutico de cancer de mama con base en estado de c-maf.
|
|
EP3296431A1
(en)
|
2016-09-15 |
2018-03-21 |
Ecole Polytechnique Fédérale de Lausanne (EPFL) |
Method of synthesis of an electrode for use as a catalyst of oxygen evolution reaction
|
|
US11654153B2
(en)
|
2017-11-22 |
2023-05-23 |
Inbiomotion S.L. |
Therapeutic treatment of breast cancer based on c-MAF status
|